ENTOD Pharmaceuticals
-
ENTOD Pharmaceuticals unveils R&D Centre in Navi Mumbai
The DSIR-approved research laboratory is equipped with the latest molecular and formulation research tools ENTOD Pharmaceuticals has inaugurated its state-of-the-art…
Read More » -
ENTOD Pharma introduces CYCLOTEARS eye drops
The first dry eye therapy to use the self-emulsifying drug delivery system technology ENTOD Pharmaceuticals has launched CYCLOTEARS eye drops…
Read More » -
Post-Budget Reaction: Nikkhil K Masurkar, CEO, Entod Pharmaceuticals
A new programme to promote R&D in pharma to be taken up through the centre of excellence is a welcome…
Read More » -
ENTOD Pharmaceuticals launches nanotech-based under-eye product in India
The product has been launched in collaboration with the UK-based cosmetic research laboratory NuSkin London ENTOD Pharmaceuticals has developed nanotechnology-based…
Read More » -
ENTOD Pharma gets DCGI nod for Phase 3 Trials of 0.05% Atropine eye drops
ENTOD Pharmaceuticals would be the first company to launch this in India subject to a successful demonstration of safety and…
Read More » -
ENTOD Pharma introduces saffron-based eye care product
The product is manufactured from 100 per cent DNA certified Persian origin natural saffron extract with guaranteed 5 per cent…
Read More » -
Budget Expectations 2022
Experts put forth their views on the upcoming Budget 2022 Saransh Chaudhary, President, Global Critical Care,…
Read More »